enVVeno Medical Statistics
Total Valuation
enVVeno Medical has a market cap or net worth of $44.98 million. The enterprise value is $4.03 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
enVVeno Medical has 17.54 million shares outstanding. The number of shares has increased by 39.36% in one year.
| Current Share Class | 17.54M |
| Shares Outstanding | 17.54M |
| Shares Change (YoY) | +39.36% |
| Shares Change (QoQ) | +26.84% |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 24.34% |
| Float | 17.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.88, with a Debt / Equity ratio of 0.03.
| Current Ratio | 20.88 |
| Quick Ratio | 20.60 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.39% and return on invested capital (ROIC) is -32.79%.
| Return on Equity (ROE) | -49.39% |
| Return on Assets (ROA) | -31.82% |
| Return on Invested Capital (ROIC) | -32.79% |
| Return on Capital Employed (ROCE) | -55.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$589,703 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.65% in the last 52 weeks. The beta is 1.03, so enVVeno Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -51.65% |
| 50-Day Moving Average | 3.17 |
| 200-Day Moving Average | 3.95 |
| Relative Strength Index (RSI) | 34.01 |
| Average Volume (20 Days) | 76,252 |
Short Selling Information
The latest short interest is 447,437, so 2.55% of the outstanding shares have been sold short.
| Short Interest | 447,437 |
| Short Previous Month | 532,712 |
| Short % of Shares Out | 2.55% |
| Short % of Float | 2.58% |
| Short Ratio (days to cover) | 4.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.83M |
| Pretax Income | -20.60M |
| Net Income | -21.82M |
| EBITDA | -23.64M |
| EBIT | -23.83M |
| Earnings Per Share (EPS) | -$1.27 |
Full Income StatementBalance Sheet
The company has $43.15 million in cash and $1.06 million in debt, giving a net cash position of $42.09 million or $2.40 per share.
| Cash & Cash Equivalents | 43.15M |
| Total Debt | 1.06M |
| Net Cash | 42.09M |
| Net Cash Per Share | $2.40 |
| Equity (Book Value) | 42.16M |
| Book Value Per Share | 2.40 |
| Working Capital | 41.64M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.84 million and capital expenditures -$37,000, giving a free cash flow of -$16.88 million.
| Operating Cash Flow | -16.84M |
| Capital Expenditures | -37,000 |
| Free Cash Flow | -16.88M |
| FCF Per Share | -$0.96 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |